Affimed N.V. (AFMDQ) vs Alaunos Therapeutics, Inc. (TCRT)
Affimed N.V. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Affimed N.V. and Alaunos Therapeutics, Inc. are of similar size ($2.9M and $2.8M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −95.2%. Alaunos Therapeutics, Inc. has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (−480.4% vs −13,558.8%). Across the 15 metrics below, Alaunos Therapeutics, Inc. leads on 8 and Affimed N.V. on 7.
Valuation
Profitability
| Metric | AFMDQ | TCRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (7,858.63%) | 0.00% | 0.00% |
| Net margin | (7,834.59%) | 0.00% | 0.00% |
| Free cash flow margin | (8,603.91%) | 0.00% | 0.00% |
| Return on equity | (148.64%) | (185.95%) | (57.72%) |
| Return on assets | (86.68%) | (128.30%) | (49.22%) |
| Return on invested capital | (13,558.83%) | (480.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack